Thrombogenesis in Thrombophilic Pregnancy: Evaluation of Low-Molecular-Weight Heparin Prophylaxis

Publisher： Karger

E-ISSN： 1421-9662|137|4|201-206

ISSN： 0001-5792

Source： Acta Haematologica, Vol.137, Iss.4, 2017-05, pp. : 201-206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

LOW‐MOLECULAR‐WEIGHT HEPARIN NOT EFFECTIVE AT PREVENTING PREGNANCY COMPLICATONS IN WOMEN WITH THROMBOPHILIAS

By  

JOURNAL OF MIDWIFERY & WOMEN'S HEALTH, Vol. 60, Iss. 1, 2015-01 ,pp. : 106-106

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-Effectiveness of Prolonged Out-of-Hospital Prophylaxis with Low-Molecular-Weight Heparin following Total Hip Replacement

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 2, 2004-11 ,pp. : 130-135

Karger

Access to resources Recommend Favorite

Staged venous thromboemolic events prophylaxis with low‐molecular‐weight heparin followed by aspirin is safe and effective after arthroplasty

By  

ANZ JOURNAL OF SURGERY, Vol. 85, Iss. 9, 2015-09 ,pp. : 652-657

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Low-Molecular-Weight Heparin on Potassium Homeostasis

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 3, 2002-10 ,pp. : 107-110

Karger

Access to resources Recommend Favorite

Evaluation of an Optimal Dose of Low-Molecular-Weight Heparin for Thromboprophylaxis in Pregnant Women at Risk of Thrombosis Using Coagulation Activation Markers

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 31, Iss. 2, 2001-10 ,pp. : 90-98

Karger

Access to resources Recommend Favorite